Clinical trials: Hospitalization
Sepsis, Necrotizing Enterocolitis
Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis
The purpose of the study is to determine whether vitamin A can improve survival and facilitate recovery from sepsis and necrotizing enterocolitis in hospitalized neonates.
- Conditions
- Sepsis, Necrotizing Enterocolitis, Meningitis, Pneumonia
- Trial name
- NCT00707785
- Testing
- Vitamin A
- Where
- Bangladesh
- Volunteers
- 424 people
- Sponsor
- Johns Hopkins University
Major Depressive Disorder, Bipolar Disorder
Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders
Mood disorders -- major depression, bipolar disorder, and dysthymia -- frequently recur; they affect one in four people during their lives. At Sunnybrook, 75% of inpatient admissions are due to mood disorders.
- Conditions
- Major Depressive Disorder, Bipolar Disorder, Dysthymia
- Trial name
- PATH-MOD (NCT01882608)
- Testing
- Mental Health Telemetry (MHT)
- Where
- Canada
- Volunteers
- 33 people
- Sponsor
- Dr. David Kreindler
Diarrhoea, Gastroenteritis
Trends Over Time (1990-2010) of Diarrhoea-related Hospitalizations and Deaths in Children < 5 Years of Age in Brazil
This study aims at collecting data to obtain baseline incidence and monitor trends over time in hospitalizations and deaths from all cause gastroenteritis in children <5 years of age, before and after implementation of Rotarix™…
- Trial name
- NCT01175252
- Testing
- Database analysis
- Where
- Brazil
- Volunteers
- 1 people
- Sponsor
- GlaxoSmithKline
Lung Transplantation
Effect of Early Pulmonary Rehabilitation After Lung Transplantation
The purpose of this observation study is to evaluate the effects of an early, 3 week lasting rehabilitation program, that starts roundabout 4 weeks after lung or combined lung transplantation, on physical activity, functional and…
- Trial name
- NCT00759538
- Where
- Germany
- Volunteers
- 120 people
- Sponsor
- Hannover Medical School
Respiratory Syncytial Viral (RSV) Infections
Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is a leading cause of hospitalizations for acute lower respiratory tract infection (LRTI) in infants.
- Trial name
- NCT06993753
- Where
- Australia
- Volunteers
- 4,350 people
- Sponsor
- Griffith University
Necrotizing Enterocolitis
Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Hospitalization
The study investigators hypothesize that Clostridium butyricum and Clostridium neonatal will be more frequently found in the stool of preterm infants with ulcerative necrotizing enterocolitis compared to healthy matched control…
- Trial name
- ECUN-2 (NCT04584320)
- Testing
- Stool sample
- Where
- France
- Volunteers
- 40 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Covid19
Case Fatalities in Hospitalised COVID-19 Patients in the UK
This study will investigate how the case fatality in hospitalised patients with COVID-19 has changed throughout the pandemic. It will also explore possible mechanisms that could be driving these changes.
- Trial name
- NCT04527458
- Testing
- Patient Characteristics, COVID-19 treatments, Differences in triage
- Where
- United Kingdom
- Volunteers
- 70,000 people
- Sponsor
- University of Edinburgh
Tuberculosis, Severe Acute Malnutrition
Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)
TB-Speed SAM is a multicentric, prospective diagnostic cohort study conducted in two countries with high and very high TB incidence (Uganda and Zambia).
- Trial name
- NCT04240990
- Testing
- Development of a score and algorithm for TB treatment decision in hospitalised children with SAM.
- Where
- 3 sites in Uganda, Zambia
- Volunteers
- 603 people
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
Liver Injury
Liver Injury in Patients With COVID-19
Coronavirus disease was first diagnosed in December 2019, in the city of Wuhan, China. The World Health Organization recently declared coronavirus disease 2019 (COVID-19) as a pandemic.
- Trial name
- NCT04358380
- Testing
- Liver injury
- Where
- Argentina
- Volunteers
- 320 people
- Sponsor
- Austral University, Argentina
COVID 19
Eccentric Cycling Vs. Standard Rehabilitation for Post-ICU Recovery in COVID-19 Survivors
We performed a longitudinal crossover clinical study on survivors of COVID-19. We compared a standard rehabilitation protocol using elastic bands versus a novel eccentric cycling training protocol in individuals who have been…
- Trial name
- ECC-4-COVID (NCT06895850)
- Testing
- Eccentric cycling training, Standar Rehabilitation
- Where
- Chile
- Volunteers
- 20 people
- Sponsor
- Universidad Nacional Andres Bello
Suicide, Suicide, Attempted
Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care
This study is being completed to examine different combinations of technology-augmented strategies to identify an effective Adaptive intervention (AI) addressing post-discharge suicide risk with high implementation potential.
- Conditions
- Suicide, Suicide, Attempted, Suicidal Ideation, Self Harm
- Trial name
- NCT05282225
- Testing
- MI- Safety Plan, Texts messages, Monitoring
- Where
- 3 sites in United States
- Volunteers
- 300 people
- Sponsor
- University of Michigan
Anxiety, Stress
Feasibility Study on the Effect of Complementary Methods as Supportive Interventions for Parents of Children With Cancer
The purpose of this study is to determine whether Guided Imagery and Progressive Muscle relaxation are effective as stress reducing techniques in parents of hospitalized children with cancer.
- Conditions
- Anxiety, Stress, Mood, Coping
- Trial name
- NCT01590524
- Testing
- Guided Imagery and Progressive Muscle Relaxation
- Where
- Cyprus
- Volunteers
- 52 people
- Sponsor
- Cyprus University of Technology
Asthma, Status Asthmaticus
Steroids in Children Hospitalized With Asthma
Asthma is the most common chronic disease of children. A short (3-5 day) course of a short-acting steroid such as Prednisone or Prednisolone has long been the standard of care for asthma exacerbation.
- Conditions
- Asthma, Status Asthmaticus, Wheezes
- Trial name
- NCT02780479
- Testing
- Dexamethasone, Prednisone
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- University of Florida
Pneumonia, Pleural Effusion
Pneumonia and Pleuropneumonia in Hospitalized Children
Describe the epidemiology of hospitalized pediatric pneumonia and pleuropneumonia with pleural effusion: frequency, clinical and biological characteristics, responsible bacteria and pneumococcus place, antibiotic resistance…
- Trial name
- NCT05274607
- Where
- France
- Volunteers
- 20,000 people
- Sponsor
- Association Clinique Thérapeutique Infantile du val de Marne
Depression, Anxiety Disorders, Psychiatric Inpatients
Cognitive Behavior Therapy in Psychiatric Inpatient Care
The current project aims to evaluate the extent to which psychological interventions based on Cognitive Behavioral Therapy (CBT), provided within the framework of care, may be helpful for patients in psychiatric inpatient care.
- Trial name
- NCT07503951
- Testing
- Cognitive Behavioral Therapy, treatment as usual (TAU) (Control Group)
- Where
- Sweden
- Volunteers
- 204 people
- Sponsor
- Region Stockholm
Kangaroo Mother Care Method
Impact of Intermittent Kangaroo Mother Care Versus Conventional Care Method on Vital Sign and Arterial Oxygen Saturation in Preterm Hospitalized in Neonatal Intensive Care Unit
To study the vital sign ,oxygen arterial saturation of preterm babies provided skin to skin contact versus conventional care from birth to discharge
- Trial name
- NCT05491265
- Testing
- Intermittent Kangaroo mother care
- Where
- Pakistan
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
Neonatal Sepsis, Low Birth Weight
Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
The purpose of this study is to examine if single skin cleansing with 0.25% chlorhexidine affects skin condition, temperature, and bacterial colonization in stable preterm (28-36 weeks gestational age) low birth weight (1001-2000…
- Trial name
- NCT00947518
- Testing
- Chlorhexidine, Normal saline
- Volunteers
- 60 people
- Sponsor
- All India Institute of Medical Sciences
COVID, Infectious Disease
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
In this study, investigators will determine whether the early addition of HT-CCP to standard treatment improves the clinical outcome (as assessed by the Modified WHO Ordinal Scale) of patients with COVID-19 who are hospitalized…
- Trial name
- (ESCAPE) (NCT04361253)
- Testing
- High-Titer COVID-19 Convalescent Plasma (HT-CCP), Standard Plasma (FFP)
- Where
- United States
- Volunteers
- 45 people
- Sponsor
- Brigham and Women's Hospital
Diarrhea, Hospitalization
Effectiveness of Adding Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
Use of zinc in diarrhea may be an effective intervention to reduce hospitalizations and child mortality as it could reach the most vulnerable children in a community and reduce severity of not only diarrhea but also of associated…
- Trial name
- NCT00278681
- Testing
- Zinc and ORS
- Where
- India
- Volunteers
- 2,364 people
- Sponsor
- Society for Applied Studies
COVID-19
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19
The primary objectives of the study are: To characterize the concentrations of casirivimab+imdevimab in serum over time To evaluate the safety and tolerability of casirivimab+imdevimab The secondary objective of the study is: To…
- Trial name
- NCT05092581
- Testing
- casirivimab+imdevimab
- Where
- 2 sites in United States
- Volunteers
- 2 people
- Sponsor
- Regeneron Pharmaceuticals